Hitachi Of Japan To Supply Proton-Beam Tech To St. Jude Of U.S.
This article was originally published in PharmAsia News
Executive Summary
Japan’s Hitachi is to supply proton-beam technology to a U.S. research hospital under a 10-year contract covering operations and maintenance.
You may also be interested in...
Warning Letter Roundup & Recap – 1 December 2020
In the only device-related warning letter released by the US FDA this week, Avazo Healthcare was selling two COVID-19 antigen tests without approval, clearance or authorization from the agency.
On-Site Inspections Of US Device Makers Plummet 93% As FDA Scrambles For Virtual Solutions
A sharp decline in the number of in-person facility inspections has forced the FDA to consider creative techniques for remotely evaluating manufacturer compliance during the COVID-19 pandemic. This and other stories topped our list of most-read Medtech Insight articles in November.
EU Health Ministers To Deliberate Over Commission’s Pharma Strategy
A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.
Need a specific report? 1000+ reports available
Buy Reports